Dr. Sherif Hanafy Mahmoud is a clinical professor at the Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta. He is also a neurocritical care clinical pharmacist at the University of Alberta Hospital. He has been involved in pharmacy practice for more than 20 years where he had many roles as a clinician, researcher and educator. Dr. Mahmoud’s research areas include epilepsy, antiseizure medications, neurocritical care pharmacotherapy and altered action and disposition of drugs in critical illness. He studies how neurological injury and other patient factors alter the pharmacokinetics and pharmacodynamics of drugs, an important avenue for personalized pharmacotherapy. This is in addition to teaching patient assessment skills in various practice settings. His approach to patient assessment is unique and exceptional as acknowledged by his students and peers. Dr. Mahmoud is a recipient of numerous awards and has numerous publications throughout his career. He is actively involved with the Neurocritical Care Society committees including the research and pharmacy leadership committees. Dr. Mahmoud has received multiple accolades for his role in neurocritical care and he is inducted as a Fellow of the Neurocritical Care Society (FNCS) for his exceptional service, academic excellence, and leadership in the field of Neurocritical care. In addition, he was named by the Canadian Pharmacists Association as the 2024 Canadian Pharmacist of the Year.
Research Keywords & Expertise
Epilepsy
Neurocritical Care
Pharmacokinetics
Subarachnoid Hemorrhag...
Antiepileptic drugs
status epilepticus
Nimodipine
Pharmacokinetic and ph...
Augmented renal cleara...
Anticonvulsants
Fingerprints
27%
Pharmacokinetics
20%
Subarachnoid Hemorrhage
18%
Antiepileptic drugs
15%
Epilepsy
11%
Nimodipine
11%
Augmented renal clearance
8%
Pharmacokinetic and pharmacodynamic studies
6%
Neurocritical Care
6%
status epilepticus
5%
Anticonvulsants
Short Biography
Dr. Sherif Hanafy Mahmoud is a clinical professor at the Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta. He is also a neurocritical care clinical pharmacist at the University of Alberta Hospital. He has been involved in pharmacy practice for more than 20 years where he had many roles as a clinician, researcher and educator. Dr. Mahmoud’s research areas include epilepsy, antiseizure medications, neurocritical care pharmacotherapy and altered action and disposition of drugs in critical illness. He studies how neurological injury and other patient factors alter the pharmacokinetics and pharmacodynamics of drugs, an important avenue for personalized pharmacotherapy. This is in addition to teaching patient assessment skills in various practice settings. His approach to patient assessment is unique and exceptional as acknowledged by his students and peers. Dr. Mahmoud is a recipient of numerous awards and has numerous publications throughout his career. He is actively involved with the Neurocritical Care Society committees including the research and pharmacy leadership committees. Dr. Mahmoud has received multiple accolades for his role in neurocritical care and he is inducted as a Fellow of the Neurocritical Care Society (FNCS) for his exceptional service, academic excellence, and leadership in the field of Neurocritical care. In addition, he was named by the Canadian Pharmacists Association as the 2024 Canadian Pharmacist of the Year.